Comparison of pulmonary CT findings and serum KL-6 levels in patients with cryptogenic organizing pneumonia

British Journal of Radiology

Volumn 82, Issue 975, 2009, Pages 212-218

  Okada, F ^a   Ando, Y ^a   Honda, K ^a   Tanoue, S ^a   Matsumoto, S ^a   Mori, H ^a  

^a OITA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN; KL 6 PROTEIN; PREDNISONE; STEROID; UNCLASSIFIED DRUG; BIOLOGICAL MARKER; C REACTIVE PROTEIN; MUC1 PROTEIN, HUMAN; MUCIN 1;

ADULT; AGED; ARTICLE; BRONCHIECTASIS; BRONCHIOLITIS OBLITERANS ORGANIZING PNEUMONIA; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; INTERMETHOD COMPARISON; MALE; PNEUMONIA; RELAPSE; RETROSPECTIVE STUDY; THORAX RADIOGRAPHY; COMPARATIVE STUDY; CYTOLOGY; DISEASE COURSE; LUNG; LUNG LAVAGE; METABOLISM; MIDDLE AGED; RADIOGRAPHY;

ADULT; AGED; BIOLOGICAL MARKERS; BRONCHOALVEOLAR LAVAGE FLUID; C-REACTIVE PROTEIN; CRYPTOGENIC ORGANIZING PNEUMONIA; DISEASE PROGRESSION; FEMALE; HUMANS; LUNG; MALE; MIDDLE AGED; MUCIN-1; RETROSPECTIVE STUDIES; TOMOGRAPHY, X-RAY COMPUTED;

EID: 62449277448     PISSN: 00071285     EISSN: None     Source Type: Journal    
DOI: 10.1259/bjr/72775434     Document Type: Article

References (31)

1. Kohno N, Kyoizumi S, Awaya Y, Fukuhara H, Yamakido M, Akiyama M. New serum indicator of interstitial pnuemonitis activity: sialyated carbohydrate antigen KL-6. Chest 1989;96:68-73.
2. Kobayashi J, Kitamura S. KL-6: A serum marker for interstitial pneumonia. Chest 1995;108:311-5.
3. Ogawa Y, Ishikawa T, Ikeda K, Nakata B, Sawada T, OgisawaK,et al. Evaluation of serum KL-6, a mucin-like glycoprotein, as a tumor marker for breast cancer. Clin Cancer Res 2000;6:4069-72.
4. Kohno N, Inoue Y, Hamada H, Fujioka S, Fujino S, Yokoyama A, et al. Difference in sero-diagnostic values among KL-6-associated mucins classified as cluster 9. Int J Cancer Suppl 1994;8:81-3.
5. Takahashi T, Takamura K, Sakaue S, Ishii J, Yokouchi H, Nasuhara Y. Elevated serum KL-6 concentrations in patients with diabetes mellitus. J Diabetes Complications 2002;16:352-8.
6. Kohno N, Akiyama M, Kyoizumi S, Hakoda M, Kobuke K, Yamakido M. Detection of soluble tumor-associated antigens in sera and effusions using novel monoclonal antibodies, KL-3 and KL-6, against lung adenocarcinoma. Jpn J Clin Oncol 1988;18:203-16.
7. Kohno N, Awaya Y, Oyama T, Yamakido M, Akiyama M, Inoue Y, et al. KL-6, a mucin-like glycoprotein, in bronchoalveolar lavage fluid from patients with interstitial lung disease. Am Rev Respir Dis 1993;148:637-42.
8. Ishii H, Mukae H, Kadota J, Kaida H, Nagata T, Abe K, et al. High serum concentrations of surfactant protein A in usual interstitial pneumonia compared with non-specific interstitial pneumonia. Thorax 2003;58:52-7.
9. American Thoracic Society, European Respiratory Society. American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias: this joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors, June 2001 and by the ERS Executive Committee, June 2001. Am J Respir Crit Care Med 2002;165:277-304.
10. Webb WR, Muller NL, Naidich DP. High-resolution computed tomography findings of lung disease. In: High-resolution CT of the lung, 3rd edn. Philadelphia, PA: Lippincott Williams & Wilkins, 2001; 71-192.
11. Austin JH, Muller NL, Friedman PJ, Hansell DM, Naidich DP, Remy-Jardin M, et al. Glossary of terms for CT of the lungs: recommendations of the Nomenclature Committee of the Fleischner Society. Radiology 1996;200:327-31.
12. Kim SJ, Lee KS, Ryu YH, Yoon YC, Choe KO, Kim TS, et al. Reversed halo sign in high-resolution CT of cryptogenic organizing pneumonia: diagnostic implications. AJR Am J Roentgenol 2003;180:1251-4.
13. Hamada H, Kohno N, Akiyama M, Hiesfs K. Monitoring of serum KL-6 antigen in a patients with radiation pneumonia. Chest 1992;101:858-60.
14. Kohno N, Hamada H, Fujioka S, Hiwada K, Yamakido M, Akiyama M. Circulating antigen KL-6 and lactate dehy- drogenase for monitoring irradiated patients with lung cancer. Chest 1992;102:117-22.
15. Kohno N, Yokoyama A, Hirasawa Y,Kondo K, Fujino S, Abe M, et al. Comparative studied of circulating KL-6, type III protocollagen N-terminal peptide and type IV collagen 7S in patients with interstitial pneumonitis and alveolar pneumonia. Respir Med 1997;91:558-61.
16. Takahashi T, Munakata M, Suzuki I, Kawakami Y. Serum and bronchoalveolar fluid KL-6 levels in patients with pulmonary alveolar proteiosis. Am J Respir Crit Care Med 1998;158:1294-8.
17. Yokoyama A, Kohno N, Hamada H, Sakatani M, Ueda E, Kondo K, et al. Circulation KL-6 predicts the outcome of rapidly progressive idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 1998;158:1680-4.
18. Hamada H, Kohno N, Yokoyama A, Hirasawa Y, Hiwada K,Sakatani M, et al. KL-6 as a serologic indicator of pneumocystis carinii pneumonia in immunocompromised hosts. Intern Med 1998;37:307-10.
19. Inoue T, Tanaka E, Sakuramoto M, Minakuchi M, Maeda Y, Maniwa K, et al. A case of cryptogenic organizing pneumonia accompanied by large bullae. Nihon Kokyuki Gakkai Zasshi 2006;44:517-21.
20. Katayama H, Yokoyama A, Hamada H, Irita J, Kadowaki T, Ito R, et al. Successful treatment of bronchiolitis obliterans organizing pneumonia with cyclosporin and steroids. Nihon Kokyuki Gakkai Zasshi 2003;41:551-5.
21. Colby TV. Pathological approach to idiopathic interstitial pneumonias: useful points for clinicians. Breathe 2004;1:43-9.
22. Iwashita T, Kadota J, Naito S, Kaida H, Ishimatsu Y, Miyazaki M, et al. Involvement of collagen-binding heat shock protein 47 and procollagen type I synthesis in idiopathic pulmonary fibrosis: contribution of type II pneumocytes to fibrosis. Hum Pathol 2000;31:1498-505.
23. Lazor R, Vandevenne A, Pelletier A, Leclerc P, Court- Fortune I, Cordier JF. Cryptogenic organizing pneumonia. Characteristics of relapses in a series of 48 patients. Am J Respir Crit Care Med 2000;162:571-7.
24. Lee KS, Kulling P, Hartman TE, Muller NL. Cryptogenic organizing pneumonia: CT findings in 43 patients. AJR Am J Roentgenol 1994;162:543-6.
25. Arakawa H, Kurihara Y, Niimi H, Nakajima Y, Johkoh T Nakamura H. Bronchiolitis obliterans with organizing pneumonia versus chronic eosinophilic pneumonia: high- resolution CT findings in 81 patients. AJR Am J Roentgenol 2001;176:1053-8.
26. Nishimura K, Itoh H. High-resolution computed tomo- graphic features of bronchiolitis obliterans organizing pneumonia. Chest 1992;102:26S-31S.
27. Bouchardy LM, Kuhlman JE, Ball WC, Hruban RH, Askin FB, Siegelman SS. CT findings in bronchiolitis obliterans organizing pneumonia (BOOP) with radiographic, clinical, and histologic correlation. J Comput Assist Tomogr 1993;17:352-7.
28. Voloudaki AE, Bouros DA, Froudarakis ME, Datseris GE, Apostolaki EG, Gourtsoyiannis NC. Crescentic and ring-shaped opacities CT features in two cased of bronchiolitis obliterans organizing pneumonia (BOOP). Acta Radiol 1996;37:889-92.
29. Akira M, Yamamoto S, Sakatani M. Bronchiolitis obliterans organizing pneumonia manifesting as multiple large nodules or masses. AJR Am J Roentgenol 1998;170:291-5.
30. Remy-Jardin M, Giraud F, Remy J, Copin MC, Gosselin B, Duhamel A. Importance of ground-glass attenuation in chronic diffuse infiltrative lung disease: pathologic-CT correlation. Radiology 1993;189:693-8.
31. Westcott JL, Cole SR. Traction bronchiectasis in end-stage pulmonary fibrosis. Radiology 1986;161:665-9.